Wednesday, April 22, 2026
29.4 C
Bengaluru

Healthcare Isn’t Working As Well As It Should – A Brief Summary Of The ZS Report 2024

The ZS report discusses how people feel about healthcare today and what can be done to improve it.

  1. Frustration with Costs: Many people find healthcare too expensive, leading to an inability to afford necessary care.
  2. Access Challenges:
    • Doctors are busy.
    • Scheduling appointments is difficult.
    • It often takes a long time to get seen.
  3. Impersonal Experience: Doctors may not have enough time to build a personal relationship with their patients.
  4. Patient Desires:
    • Affordable healthcare.
    • Easy access to services.
    • Quick appointments.
    • Convenient locations.
    • Options for online consultations.
    • More personalized care, where doctors listen to and understand patient needs.
  5. Proposed Solution: The ZS report suggests that technology, including computers and AI, can help resolve these issues.
  6. Potential Benefits of AI:
    • Assist doctors in making diagnoses more quickly and accurately.
    • Simplify the scheduling process and paperwork management.
    • Empower individuals to manage their health at home through apps and wearable devices.
  7. Challenge of Implementation:
    • Utilizing technology effectively is a complex challenge.
    • Requires collaboration between doctors, hospitals, insurance companies, and technology firms.
  8. Call for Change: The ZS report emphasizes improving healthcare through enhanced access, reduced costs, and a more patient-friendly experience, highlighting technology and collaboration as essential components for achieving these improvements.

A MedicinManAI Feature

About ZS

ZS is a management consulting and technology firm that partners with companies to improve life and
how we live it. We transform ideas into impact by combining data, science, technology, and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 13,000 employees in more than 35 offices worldwide. To learn more, visit www.zs.com or follow us on LinkedIn.

Explore the 2025 ZS Future of Health Report on ZS.com. Learn more: zs.com/futureofhealth

Pharma professionals should follow @ZSAssociates on X to stay abreast of healthcare news, insights, and surveys.

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img